19 insiders reported 43 Form 4 transactions for Braveheart Bio, Inc. (BRVE) over the past 18 months (most recent 2026-08-11). Recent activity: OrbiMed Capital GP IX LLC (Director) Buy 9.1M shares, ORBIMED ADVISORS LLC (Director) Buy 273,333 shares, AH Bio Fund IV, L.P. (10% Owner) Buy 9.1M shares, OrbiMed Genesis GP LLC (Director) Buy 9.1M shares, Chimovits Erez (Director) Buy 9.1M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | OrbiMed Capital GP IX LLC | Director | Buy | 9.1M | $0 |
| 2026-08-11 | ORBIMED ADVISORS LLC | Director | Buy | 273,333 | $4.9M |
| 2026-08-11 | AH Bio Fund IV, L.P. | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-11 | OrbiMed Genesis GP LLC | Director | Buy | 9.1M | $0 |
| 2026-08-11 | Chimovits Erez | Director | Buy | 9.1M | $0 |
| 2026-08-11 | HOROWITZ BENJAMIN A | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-11 | Andreessen Marc L | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-11 | AH Equity Partners Bio IV, L.L.C. | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-11 | OrbiMed Capital GP IX LLC | Director | Buy | 1.7M | $30.0M |
| 2026-08-11 | AH Equity Partners Bio IV, L.L.C. | 10% Owner | Buy | 1.1M | $19.8M |
| 2026-08-11 | AH Bio Fund IV, L.P. | 10% Owner | Buy | 1.1M | $19.8M |
| 2026-08-11 | OrbiMed Genesis GP LLC | Director | Buy | 1.7M | $30.0M |
| 2026-08-11 | Chimovits Erez | Director | Buy | 1.7M | $30.0M |
| 2026-08-11 | HOROWITZ BENJAMIN A | 10% Owner | Buy | 1.1M | $19.8M |
| 2026-08-11 | Andreessen Marc L | 10% Owner | Buy | 1.1M | $19.8M |
| 2026-08-11 | ORBIMED ADVISORS LLC | Director | Buy | 1.7M | $30.0M |
| 2026-08-11 | OrbiMed Capital GP IX LLC | Director | Buy | 273,333 | $4.9M |
| 2026-08-11 | OrbiMed Genesis GP LLC | Director | Buy | 273,333 | $4.9M |
| 2026-08-11 | Chimovits Erez | Director | Buy | 273,333 | $4.9M |
| 2026-08-11 | ORBIMED ADVISORS LLC | Director | Buy | 9.1M | $0 |
| 2026-08-10 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% Owner | Buy | 7.4M | $0 |
| 2026-08-07 | Forbion Ventures VII Management B.V. | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-07 | Forbion Ventures Fund VII Cooperatief U.A. | 10% Owner | Buy | 9.1M | $0 |
| 2026-08-07 | Anderson Michele A. | Chief Development Officer | Buy | 1,111 | $19,998 |
| 2026-08-07 | Malek David I | Director | Buy | 4,166 | $74,988 |
Source: SEC Form 4 filings · as of 2026-08-11